Articles by Hellen Berger - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Hellen Berger

Hellen Berger


Hellen Berger is a business writer based in Sao Paulo, Brazil.

Articles
Global Instability Affects the Pharma Market in Brazil
April 2, 2014

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?

Innovation and Market Growth in Brazil
January 2, 2014

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.

Report from Brazil
November 2, 2013

New regulation offers patients in Brazil greater access to experimental drugs.

Report from Brazil
September 2, 2013

Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.

Report from Brazil
July 2, 2013

Brazil offers opportunities and challenges for global pharmaceutical companies.

Report from Brazil
May 2, 2013

Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.

Report from Brazil
March 2, 2013

Brazil's major vaccine producer innovates with stem-cell research.

Report from Brazil
January 1, 2013

The health ministry of Brazil recently signed an agreement to obtain its production technology to locally develop the antiretroviral drug atazavanir sulfate.

Report from Brazil
September 2, 2012

Brazil takes first steps towards gaining quality requirements for pharmaceutical excipients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
28%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
33%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here